Stephen F. Betz - 16 Dec 2024 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role: Chief Scientific Officer
Signature: Marc Wilson, as attorney-in-fact
Issuer symbol: CRNX
Transactions as of: 16 Dec 2024
Net transactions value: +$4,452
Form type: 4
Filing time: 18 Dec 2024, 16:30:03 UTC
Previous filing: 12 Sep 2024
Next filing: 29 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRNX	Common Stock	Options Exercise	$4,452	+2,331	+3.4%	$1.91	71,358	16 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRNX	Stock Option (Right to Buy)	Options Exercise	$0	-2,331	-1.3%	$0.000000	180,039	16 Dec 2024	Common Stock	2,331	$1.91	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.